Find Reports
Select Report Type
Reimbursement Review
Displaying 1376 - 1400 of 1422
Please scroll or swipe to the right to view the full content.
| Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|---|
| abemaciclib | Verzenio | abemaciclib | HR-positive, HER2-negative advanced or metastatic breast cancer | Active | PC0409-000 | ||||
| asciminib | Scemblix | asciminib | Philadelphia chromosome-positive chronic myeloid leukemia | Active | PC0418-000 | ||||
| ruxolitinib | Opzelura | ruxolitinib | atopic dermatitis | Active | SR0807-000 | ||||
| pembrolizumab | Keytruda | pembrolizumab | Non-Small Cell Lung Cancer, neoadjuvant | Active | PC0385-000 | ||||
| belzutifan | Welireg | belzutifan | advanced renal cell carcinoma (RCC) | Active | PC0386-000 | ||||
| pembrolizumab | Keytruda | pembrolizumab | Advanced or metastatic malignant pleural mesothelioma | Active | PC0387-000 | ||||
| pembrolizumab | Keytruda | pembrolizumab | Head and neck squamous cell carcinoma | Active | PC0410-000 | ||||
| pembrolizumab | Keytruda | pembrolizumab | Cervical cancer | Active | PC0411-000 | ||||
| acalabrutinib | Calquence | acalabrutinib | Mantle cell lymphoma (MCL) | Active | PC0413-000 | ||||
| semaglutide | Wegovy | semaglutide | Weight management | Active | SR0841-000 | ||||
| teprotumumab | TBC | teprotumumab | Thyroid Eye Disease (TED), active | Active | SR0853-000 | ||||
| bimekizumab | Bimzelx | bimekizumab | Hidradenitis suppurative | Active | SR0856-000 | ||||
| crovalimab | TBC | crovalimab | paroxysmal nocturnal hemoglobinuria (PNH) | Active | SR0858-000 | ||||
| fecal microbiota | Rebyota | fecal microbiota | Clostridioides difficile infection, prevention | Active | SR0850-000 | ||||
| ferric carboxymaltose | Ferinject | ferric carboxymaltose | Iron deficiency in adult patients with heart failure | Active | SR0852-000 | ||||
| olopatadine hydrochloride and ... | Ryaltris | olopatadine hydrochloride and mometasone | Seasonal allergic rhinitis | Active | SR0848-000 | ||||
| elafibranor | TBC | elafibranor | Primary biliary cholangitis (PBC) | Active | SR0865-000 | ||||
| teplizumab | Tzield | teplizumab | Delay onset of Stage 3 Type 1 Diabetes | Active | SR0867-000 | ||||
| nemolizumab | TBC | nemolizumab | atopic dermatitis | Active | SR0869-000 | ||||
| Dupilumab | Dupixent | Dupilumab | Chronic obstructive pulmonary disease (COPD) | Active | SR0870-000 | ||||
| daridorexant | Quviviq | daridorexant | Insomnia | Active | SR0862-000 | ||||
| omaveloxolone | Skyclarys | omaveloxolone | Friedreich’s ataxia | Active | SR0864-000 | ||||
| cipaglucosidase alfa and miglu... | TBC | cipaglucosidase alfa and miglustat | Pompe disease | Active | SR0871-000 | ||||
| guselkumab | Tremfya | guselkumab | Ulcerative colitis | Active | SR0874-000 | ||||
| dupilumab | Dupixent | dupilumab | Prurigo nodularis (PN) | Active | SR0876-000 |
Health Technology Review
Displaying 576 - 600 of 600
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 27 of 27
View All Reports
Displaying 1376 - 1400 of 2132
Please scroll or swipe to the right to view the full content.